Positron emission tomography/computed tomography (PET/CT) is a hybrid medical imaging technique that combines PET and CT to provide detailed images of the body's anatomical structures and metabolic activity. It is frequently used for oncology and oth...
BACKGROUND AND OBJECTIVE: Positron emission tomography/computed tomography (PET/CT) is recommended as the standard imaging modality for diffuse large B-cell lymphoma (DLBCL) staging. However, many studies have neglected the role of patients' prognost...
BACKGROUND: This study aims to develop habitat radiomic models to predict overall survival (OS) for hepatocellular carcinoma (HCC), based on the characterization of the intratumoral heterogeneity reflected in F-FDG PET/CT images.
Cancer imaging : the official publication of the International Cancer Imaging Society
Nov 12, 2024
BACKGROUND: To develop an artificial intelligence (AI)-based model using Radiomics, deep learning (DL) features extracted from F-fluorodeoxyglucose (F-FDG) Positron emission tomography/Computed Tomography (PET/CT) images of tumor and cervical lymph n...
INTRODUCTION: Head and neck cancers are the seventh most common globally, with lymph node metastasis (LNM) being a critical prognostic factor, significantly reducing survival rates. Traditional imaging methods have limitations in accurately diagnosin...
OBJECTIVES: This study aimed to develop an integrated segmentation-free deep learning (DL) framework to predict multiple aspects of radiotherapy outcome in pharyngeal cancer patients by analyzing pretreatment 18F-fluorodeoxyglucose (18F-FDG) positron...
RATIONALE AND OBJECTIVES: Misregistration artifacts between the PET and attenuation correction CT (CTAC) exams can degrade image quality and cause diagnostic errors. Deep learning (DL)-warped elastic registration methods have been proposed to improve...
The purpose of this paper is to provide an overview of the cutting-edge applications of artificial intelligence (AI) technology in total-body positron emission tomography/computed tomography (PET/CT) scanning technology and its profound impact on the...
INTRODUCTION: Primary refractory disease affects 30-40% of patients diagnosed with DLBCL and is a significant challenge in disease management due to its poor prognosis. Predicting refractory status could greatly inform treatment strategies, enabling ...
INTRODUCTION: Lutetium-177 (Lu-177) prostate-specific membrane antigen (PSMA) therapy is a radionuclide treatment that prolongs overall survival in metastatic castration-resistant prostate cancer (MCRPC). We aimed to predict lesion-based treatment re...
Join thousands of healthcare professionals staying informed about the latest AI breakthroughs in medicine. Get curated insights delivered to your inbox.